Recently, ROCK has beenhighlighted as an interesting target forthe treatment of Alzheimer's Disease (AD). The RhoA/ROCK signaling pathway modulates the hydrolysisof theamyloid-β protein precursor (APP), which causes amyloid-β(Aβ) accumulation and increased neurotoxicity. The gene discussed is APP; the disease is Alzheimer disease.